Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Decreasing prevalence of Hepatitis B and absence of Hepatitis C Virus infection in the Warao indigenous population of Venezuela.

Blanco RY, Loureiro CL, Villalba JA, Sulbarán YF, Maes M, de Waard JH, Rangel HR, Jaspe RC, Pujol FH.

PLoS One. 2018 May 25;13(5):e0197662. doi: 10.1371/journal.pone.0197662. eCollection 2018.

2.

Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.

Jourdain G, Ngo-Giang-Huong N, Harrison L, Decker L, Khamduang W, Tierney C, Salvadori N, Cressey TR, Sirirungsi W, Achalapong J, Yuthavisuthi P, Kanjanavikai P, Na Ayudhaya OP, Siriwachirachai T, Prommas S, Sabsanong P, Limtrakul A, Varadisai S, Putiyanun C, Suriyachai P, Liampongsabuddhi P, Sangsawang S, Matanasarawut W, Buranabanjasatean S, Puernngooluerm P, Bowonwatanuwong C, Puthanakit T, Klinbuayaem V, Thongsawat S, Thanprasertsuk S, Siberry GK, Watts DH, Chakhtoura N, Murphy TV, Nelson NP, Chung RT, Pol S, Chotivanich N.

N Engl J Med. 2018 Mar 8;378(10):911-923. doi: 10.1056/NEJMoa1708131.

PMID:
29514030
3.

Current Progress of Virus-mimicking Nanocarriers for Drug Delivery.

Somiya M, Liu Q, Kuroda S.

Nanotheranostics. 2017 Oct 31;1(4):415-429. doi: 10.7150/ntno.21723. eCollection 2017. Review.

4.

Characterization of hepatitis B virus in Amerindian children and mothers from Amazonas State, Colombia.

Jaramillo CM, de La Hoz F, Porras A, di Filippo D, Choconta-Piraquive LA, Payares E, Montes N, Navas MC.

PLoS One. 2017 Oct 10;12(10):e0181643. doi: 10.1371/journal.pone.0181643. eCollection 2017.

5.

Do we need better hepatitis B vaccines?

Gerlich WH.

Indian J Med Res. 2017 Apr;145(4):414-419. doi: 10.4103/ijmr.IJMR_1852_16. No abstract available.

6.

Temporal trend of hepatitis B surface mutations in the post-immunization period: 9 years of surveillance (2005-2013) in eastern China.

Yan B, Lv J, Feng Y, Liu J, Ji F, Xu A, Zhang L.

Sci Rep. 2017 Jul 27;7(1):6669. doi: 10.1038/s41598-017-07085-z.

7.

Detection and molecular characterisation of a diagnosis escape variant associated with occult hepatitis B virus in Brazil.

Almeida RW, Mello FCDA, Menegoy IV, Santo MPDE, Ginuíno CF, Sousa PSF, Villar LM, Lampe E, Lewis-Ximenez LL.

Mem Inst Oswaldo Cruz. 2017 Jul;112(7):485-491. doi: 10.1590/0074-02760160477.

8.

Characteristics of escape mutations from occult hepatitis B virus infected patients with hematological malignancies in South Egypt.

Elkady A, Iijima S, Aboulfotuh S, Mostafa Ali E, Sayed D, Abdel-Aziz NM, Ali AM, Murakami S, Isogawa M, Tanaka Y.

World J Hepatol. 2017 Mar 28;9(9):477-486. doi: 10.4254/wjh.v9.i9.477.

9.

Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co-infected Nigerians.

Grant J, Agbaji O, Kramvis A, Yousif M, Auwal M, Penugonda S, Ugoagwu P, Murphy R, Hawkins C.

Trop Med Int Health. 2017 Jun;22(6):744-754. doi: 10.1111/tmi.12873. Epub 2017 May 22.

10.

Why does drug resistance readily evolve but vaccine resistance does not?

Kennedy DA, Read AF.

Proc Biol Sci. 2017 Mar 29;284(1851). pii: 20162562. doi: 10.1098/rspb.2016.2562. Review.

11.

The Envelope Gene of Hepatitis B Virus Is Implicated in Both Differential Virion Secretion and Genome Replication Capacities between Genotype B and Genotype C Isolates.

Jia H, Qin Y, Chen C, Zhang F, Li C, Zong L, Wang Y, Zhang J, Li J, Wen Y, Tong S.

Viruses. 2017 Mar 28;9(4). pii: E62. doi: 10.3390/v9040062.

12.

Complete and Incomplete Hepatitis B Virus Particles: Formation, Function, and Application.

Hu J, Liu K.

Viruses. 2017 Mar 21;9(3). pii: E56. doi: 10.3390/v9030056. Review.

13.

Investigation of a Novel Hepatitis B Virus Surface Antigen (HBsAg) Escape Mutant Affecting Immunogenicity.

Hossain MG, Ueda K.

PLoS One. 2017 Jan 3;12(1):e0167871. doi: 10.1371/journal.pone.0167871. eCollection 2017.

14.

Biological characteristics comparison of HBV rtA181T mutants with truncated or substituted HBsAg expression in vitro and in vivo model systems.

Zhou LY, Chen EQ, Wang ML, Chen LL, Liu CP, Zeng F, Tang H.

Sci Rep. 2016 Dec 15;6:39260. doi: 10.1038/srep39260.

15.

Update on occult hepatitis B virus infection.

Makvandi M.

World J Gastroenterol. 2016 Oct 21;22(39):8720-8734. Review.

16.

Evaluation of the G145R Mutant of the Hepatitis B Virus as a Minor Strain in Mother-to-Child Transmission.

Komatsu H, Inui A, Umetsu S, Tsunoda T, Sogo T, Konishi Y, Fujisawa T.

PLoS One. 2016 Nov 3;11(11):e0165674. doi: 10.1371/journal.pone.0165674. eCollection 2016.

17.

Molecular epidemiology of hepatitis B virus isolated from Bangladesh.

Shaha M, Hoque SA, Rahman SR.

Springerplus. 2016 Sep 8;5(1):1513. doi: 10.1186/s40064-016-3174-5. eCollection 2016.

18.

Current progress in the development of therapeutic vaccines for chronic hepatitis B virus infection.

Ghasemi F, Rostami S, Ghayour-Mobarhan M, Meshkat Z.

Iran J Basic Med Sci. 2016 Jul;19(7):692-704. Review.

19.

Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.

Jourdain G, Ngo-Giang-Huong N, Cressey TR, Hua L, Harrison L, Tierney C, Salvadori N, Decker L, Traisathit P, Sirirungsi W, Khamduang W, Bowonwatanuwong C, Puthanakit T, Siberry GK, Watts DH, Murphy TV, Achalapong J, Hongsiriwon S, Klinbuayaem V, Thongsawat S, Chung RT, Pol S, Chotivanich N.

BMC Infect Dis. 2016 Aug 9;16:393. doi: 10.1186/s12879-016-1734-5.

20.

Hepatitis B Virus Infection in Indonesia 15 Years After Adoption of a Universal Infant Vaccination Program: Possible Impacts of Low Birth Dose Coverage and a Vaccine-Escape Mutant.

Purwono PB, Juniastuti, Amin M, Bramanthi R, Nursidah, Resi EM, Wahyuni RM, Yano Y, Soetjipto, Hotta H, Hayashi Y, Utsumi T, Lusida MI.

Am J Trop Med Hyg. 2016 Sep 7;95(3):674-9. doi: 10.4269/ajtmh.15-0121. Epub 2016 Jul 11.

Supplemental Content

Support Center